Travere Therapeutics TVTX
NASDAQ TVTX
$58.86 -1.13 (-1.88%)
At close: Sep 30, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Debt Ratio (2011 - 2025)

Updated

Travere Therapeutics' Debt Ratio came in at 0.12 for Q2 2025, down 1.1% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Debt Ratio (2011 - 2025) Analysis & Trends

Going back to Q3 2014, Travere Therapeutics' Debt Ratio data covers 12 quarters.

  • The five-year range for quarterly Debt Ratio is 0.12 (Q4 2024) to 0.14 (Q3 2024).
  • Business Quant data shows TVTX's Debt Ratio at 0.13 (Q1 2025), 0.12 (Q4 2024) and 0.14 (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Travere Therapeutics 5.65 Bn 5.25 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.12
Mar 31, 2025 0.13
Dec 31, 2024 0.12
Sep 30, 2024 0.14
Mar 31, 2019 0.03
Dec 31, 2018 0.03
Sep 30, 2018 0.03
Jun 30, 2018 0.09
Jun 30, 2015 0.10
Mar 31, 2015 0.10
Dec 31, 2014 0.30
Sep 30, 2014 0.28
Nov 30, 2011 6.43
Feb 28, 2011 6,316.32
API Access

Travere Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=TVTX&period=max&api_key=YOUR_API_KEY